Harvard Bioscience Inc. (HBIO)
NASDAQ: HBIOIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
HBIO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $38.69M
- Forward P/E
- 13.18
- EPS (TTM)
- -$2.31
- Dividend yield
- None
- 52-week range
- 3.80 – 9.40
- Day range
- 8.43 – 8.60
- Volume / Avg
- 8.28K / 18.02K
- Beta
- —
- Shares outstanding
- 4.55M
- Next earnings
- Nov 5, 2026
52-week range
HBIO stock today
Harvard Bioscience (HBIO) closed at $8.50 on Oct 7, down 0.70% (-$0.06), versus the S&P 500's 0.22% decline. Trading was light, with 8.28K shares changing hands, about 46% of the average daily volume. At this level, HBIO sits near the top of its 52-week range of $3.80 to $9.40: 9.6% below the high, set on Oct 30, 2025 and 123.7% above the low.
HBIO is up 26.9% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 93.2%. Harvard Bioscience has posted a net loss over the last twelve months (EPS of -$2.31), so its P/E ratio is not meaningful. Harvard Bioscience's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Harvard Bioscience
Company profile- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Headquarters
- Holliston, MA
- IPO year
- 2000
Earnings
Earnings history- Next report
- Nov 5, 2026
Harvard Bioscience peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PRPOPrecipio Inc. | 23.52 | +0.30% | $42.11M | vs HBIO |
| RPIDRapid Micro Biosystems Inc. Class A | 0.8977 | -4.76% | $45.03M | vs HBIO |
| CIRCCircle8 Group Inc. | 0.46 | -7.26% | $52.63M | vs HBIO |
| BNGOBionano Genomics Inc. | 1.46 | +0.69% | $17.19M | vs HBIO |
| ASTCAstrotech Corporation (DE) | 6.86 | +2.16% | $14.41M | vs HBIO |
| SEERSeer Inc. Class A | 2.21 | +0.91% | $122.37M | vs HBIO |
| QTRXQuanterix Corporation | 3.33 | -3.34% | $157.25M | vs HBIO |
| NAUTNautilus Biotechnology Inc. | 1.96 | +10.73% | $249.42M | vs HBIO |
Indexes, lists and sector
Harvard Bioscience stock FAQ
What is Harvard Bioscience's stock price today?
HBIO last traded at $8.50 as of Oct 7, 4:00 PM EDT, down 0.70% on the day. Prices are delayed at least 15 minutes.
Does Harvard Bioscience pay a dividend?
No. Harvard Bioscience does not currently pay a regular cash dividend.
When is Harvard Bioscience's next earnings date?
Harvard Bioscience is expected to report earnings on Thursday, November 5, 2026.
Has HBIO ever split its stock?
Yes. The most recent HBIO stock split was a 1-for-10 split on Mar 16, 2026, one of 2 splits on record.
What is the HBIO 52-week high?
The 52-week high for HBIO is $9.40 and the 52-week low is $3.80. The stock is currently 9.6% below its high.